✦ LIBER ✦

Cytomegalovirus infection in orthotopic liver transplantation

✍ Scribed by L. H. Sayage; T. A. Gonwa; R. M. Goldstein; B. S. Husberg; G. B. Klintmalm

Publisher: Springer
Year: 1989
Tongue: English
Weight: 610 KB
Volume: 2
Category: Article
ISSN: 0934-0874
DOI: 10.1007/bf02459327

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytomegalovirus infection after liver tr

Cytomegalovirus infection after liver transplantation

✍ Raymund R. Razonable 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Key Points 1. Cytomegalovirus (CMV) is a common infection after liver transplantation and manifests as an asymptomatic infection or clinically as CMV syndrome (fever and myelosuppression) or tissue-invasive CMV disease. 2. The most common risk factor for CMV disease is donor positivity and recip

Management of cytomegalovirus infection

Management of cytomegalovirus infection after liver transplantation

✍ Priya Sampathkumar; Carlos V. Paya 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

C ytomegalovirus (CMV) is a ubiquitous herpes virus that, together with human herpesvirus type 6 (HHV-6) and HHV-7, belongs to the β-herpesvirus family. Like other herpes viruses, CMV establishes lifelong latent infections. Infection with CMV is common in all populations, but is infrequently associa

Is cytomegalovirus infection dangerous i

Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation?

✍ Jong Man Kim; Sung-Joo Kim; Jae-Won Joh; Choon Hyuck David Kwon; Sanghyun Song; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Cytomegalovirus (CMV) infections contracted after liver transplantation put patients at an increased risk of morbidity and mortality. We analyzed the effects of CMV infection by time of onset, mortality, and graft failure risk factors in liver recipients who were CMV donor-positive/recipient-positiv

Donated organ as a source of cytomegalov

Donated organ as a source of cytomegalovirus in orthotopic liver transplantation

✍ Dr. Sheena Sutherland; Paul Bracken; Tim G. Wreghitt; John O'Grady; Roy Y. Calne 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

## Abstract The importance of the donated organ as a source of CMV was assessed in 120 patients following orthotopic liver transplant and the CMV infections that developed in these patients were graded by severity. Forty‐four recipients were CMV antibody negative pre‐transplant. Eighteen of these r

Impact of cytomegalovirus prophylaxis on

Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation

✍ Michelle Slifkin; Robin Ruthazer; Richard Freeman; Judy Bloom; Susan Fitzmaurice 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

With improved cytomegalovirus (CMV) prophylaxis, CMV disease after liver transplantation has decreased dramatically, and patient and graft survival have improved. We examined the impact of CMV prophylaxis on biopsy proven rejection after orthotopic liver transplantation by analyzing data on 192 live

Epstein-Barr virus infection in 59 ortho

Epstein-Barr virus infection in 59 orthotopic liver transplant patients

✍ M. E. Lamy; A. M. Favart; C. Cornu; M. Salizzoni; N. Cimadamore; B. Hemptinne; J 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 380 KB

Fifty-nine orthotopic liver transplant (OLT) patients were studied after transplantation to detect Epstein-Barr virus (EBV) primoinfection and reactivation. Nineteen, all children under 10 years, were EBV seronegative. Seroconversion occurred in 12 (63.3%) of the seronegative patients. Most of these